EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Parenteral vaccination with recombinant EtpA glycoprotein impairs enterotoxigenic E. coli colonization

Tim J Vickers, David P Buckley, Nazia Khatoon, Alaullah Sheikh, Bipul Setu, Zachary T Berndsen, James M Fleckenstein iD

Infection and Immunity · 2025

DOI: 10.1128/iai.00601-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infection and Immunity, 2025. Verfasst von Tim J Vickers und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA. Hauptthemen laut MEDLINE: Enterotoxigenic Escherichia coli, Escherichia coli Infections, Escherichia coli Vaccines, Escherichia coli Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Enterotoxigenic E. coli (ETEC) causes hundreds of millions of cases of acute diarrheal illness in low- and middle-income regions, disproportionately in young children. To date, there is no licensed, broadly protective vaccine against these common but antigenically heterogeneous pathogens. One of the more highly conserved antigens of ETEC, EtpA, is an extracellular glycoprotein adhesin that preferentially binds to A blood group glycans on intestinal epithelia. EtpA contributes to increased severity of illness in A blood group individuals, elicits robust serologic and fecal antibody responses following infection, and has been associated with protection against subsequent infection. However, its utility as a protective antigen needs further examination. In the present studies, we examined whether parenteral vaccination with recombinant EtpA (rEtpA) could afford protection against intestinal colonization in a murine model of ETEC infection. Here, we demonstrate that intramuscular vaccination with rEtpA, adjuvanted with double mutant LT (dmLT), primes IgG predominant mucosal antibody responses to ETEC challenge. Notably, however, both antibody levels and avidity, as well as protection, were dependent on the vaccination schedule. Likewise, through electron microscopy polyclonal epitope mapping (EMPEM), we observed a different repertoire of epitopes targeted by antibodies after a more protracted vaccination schedule. Next, we explored the utility of IM immunization with alum-adjuvanted rEtpA. This elicited strong serologic and fecal IgG responses. Although accompanied by negligible IgA mucosal responses, EtpA alum-adjuvanted IM vaccination nevertheless protected against ETEC intestinal colonization. Collectively, these data suggest that EtpA could expand the portfolio of antigens targeted in ETEC subunit vaccine development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Enterotoxigenic Escherichia coliEscherichia coli InfectionsEscherichia coli VaccinesEscherichia coli ProteinsAnimalsMiceAntibodies, BacterialFemaleRecombinant ProteinsImmunoglobulin GVaccinationMice, Inbred BALB CDisease Models, AnimalMembrane Glycoproteins

Stichwörter der Autor:innen

adhesinsdiarrheaenterotoxigenic Escherichia coliheat-labile toxinimmunization

Substanzen

Escherichia coli VaccinesEscherichia coli ProteinsAntibodies, BacterialEtpA protein, E coliRecombinant ProteinsImmunoglobulin GMembrane Glycoproteins

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Department of Biochemistry, University of Missouri Columbia, Columbia, Missouri, USA.
  • Infectious Diseases, Medicine Service, Veterans Affairs Saint Louis Health Care System, St. Louis, Missouri, USA.

ORCID-Profile: James M Fleckenstein

Förderung

  • BLRD VA
  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • U.S. Department of Veterans Affairs

Zitieren

APA

Vickers, T. J., Buckley, D. P., Khatoon, N., Sheikh, A., Setu, B., Berndsen, Z. T., & Fleckenstein, J. M. (2025). Parenteral vaccination with recombinant EtpA glycoprotein impairs enterotoxigenic E. coli colonization. Infection and Immunity. https://doi.org/10.1128/iai.00601-24

Vancouver

Vickers TJ, Buckley DP, Khatoon N, Sheikh A, Setu B, Berndsen ZT, et al. Parenteral vaccination with recombinant EtpA glycoprotein impairs enterotoxigenic E. coli colonization. Infection and Immunity. 2025. doi:10.1128/iai.00601-24

BibTeX
@article{Vickers2025,
  author = {Vickers, Tim J and Buckley, David P and Khatoon, Nazia and Sheikh, Alaullah and Setu, Bipul and Berndsen, Zachary T and Fleckenstein, James M},
  title = {Parenteral vaccination with recombinant EtpA glycoprotein impairs enterotoxigenic E. coli colonization},
  journal = {Infection and Immunity},
  year = {2025},
  doi = {10.1128/iai.00601-24}
}
Kostenlos starten →